Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis.
about
The Krüppel-like factor KLF2 inhibits peroxisome proliferator-activated receptor-gamma expression and adipogenesisCyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitmentSIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1's repressive interaction with PPARgammaPeroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinomaA novel mechanism of PPAR gamma induction via EGFR signalling constitutes rational for combination therapy in bladder cancerHzf regulates adipogenesis through translational control of C/EBPalphaHistone methylation regulator PTIP is required for PPARgamma and C/EBPalpha expression and adipogenesisThe Krüppel-like factor KLF15 regulates the insulin-sensitive glucose transporter GLUT4Regulation of tristetraprolin during differentiation of 3T3-L1 preadipocytesAltered prostatic epithelial proliferation and apoptosis, prostatic development, and serum testosterone in mice lacking cyclin-dependent kinase inhibitorsMicroRNA and 3T3-L1 pre-adipocyte differentiationProteomic analysis of primary cultures of human adipose-derived stem cells: modulation by Adipogenesis.Therapeutic Implications of PPARgamma in Human Osteosarcoma.Molecular Characterization of the Tumor Suppressor Candidate 5 Gene: Regulation by PPARgamma and Identification of TUSC5 Coding Variants in Lean and Obese Humans.Multiple roles for the non-coding RNA SRA in regulation of adipogenesis and insulin sensitivity.Impact of reference gene selection for target gene normalization on experimental outcome using real-time qRT-PCR in adipocytes.Gene expression profiling of subcutaneous adipose tissue in morbid obesity using a focused microarray: distinct expression of cell-cycle- and differentiation-related genesTranscriptional regulatory program in wild-type and retinoblastoma gene-deficient mouse embryonic fibroblasts during adipocyte differentiation.Inhibition of adipogenesis by Tempol in 3T3-L1 cells.Cyclin D3 promotes adipogenesis through activation of peroxisome proliferator-activated receptor gamma.Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolismThe G0/G1 switch gene 2 is a novel PPAR target gene.Regulation of adipocyte differentiation.The effect of insulin, TNFα and DHA on the proliferation, differentiation and lipolysis of preadipocytes isolated from large yellow croaker (Pseudosciaena Crocea R.).Identification of Creb3l4 as an essential negative regulator of adipogenesisProinflammatory cytokine production and insulin sensitivity regulated by overexpression of resistin in 3T3-L1 adipocytes.G protein-coupled receptors and adipogenesis: a focus on adenosine receptors.Menin represses tumorigenesis via repressing cell proliferation.Promyelocytic leukemia inhibits adipogenesis, and loss of promyelocytic leukemia results in fat accumulation in mice.PPARγ Promotes Growth and Invasion of Thyroid Cancer CellsCyclin-dependent kinase inhibitor, p21WAF1/CIP1, is involved in adipocyte differentiation and hypertrophy, linking to obesity, and insulin resistance.Transcriptional control of adipocyte formation.Emerging roles for the transforming growth factor-{beta} superfamily in regulating adiposity and energy expenditureAtypical transcriptional regulators and cofactors of PPARgamma.Solid tumor differentiation therapy - is it possible?Peroxisome proliferator-activated receptor-gamma ligands for the treatment of breast cancer.In utero growth restriction and catch-up adipogenesis after developmental di (2-ethylhexyl) phthalate exposure cause glucose intolerance in adult male rats following a high-fat dietary challenge.Modulation of IL-27 in adipocytes during inflammatory stress.PPARgamma and MEK Interactions in CancerPresent concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer.
P2860
Q28214487-DF60B2F5-87E4-462E-B188-45C4B19EE308Q28235209-B9BE89F7-601B-4B97-9CB0-3A74DB4212F0Q28301961-3E6D4DBB-D89C-4016-90F0-9AED2FAC70D1Q28366616-B012976F-9A81-4A4A-8961-F921DD3978E2Q28486089-FEAE8540-1BB2-4E97-82C8-EBEB404EC994Q28507261-7F2E3440-9DB0-400A-B86D-5C3157AA7E48Q28513731-233A93A0-DC84-4105-9678-95E53B8A042AQ28585457-CAD47BCB-27B1-4EB8-ABCD-6975240EB6ECQ28588372-8BD4917E-67F9-42EF-A64D-7361390F5EF3Q28591408-079084CB-B4BB-466F-8202-8DC1BB452C8EQ30820724-8EAFBA38-3219-4915-9BBA-3A91F09E3A41Q31151929-2287FCA1-D7F1-42F0-A4CA-DAC683A4A74CQ33674615-D70D74F9-BAF9-4938-BEB3-7671A47B3F73Q33696469-75922349-06AA-4296-A895-BF152A9C5F56Q33769840-E0F5DD1A-225E-4E09-B0B1-AEB5800DCDA7Q33778424-E3584BFE-8ECB-4BA9-9AFD-2C6ECA1F7371Q33779549-9A40ED43-7653-4C62-9267-CC49AAC5C7CAQ33912962-A42E637F-AEE9-4307-9369-A45A16574004Q33998448-10D13603-F7A8-4C49-89C8-9EF35349BE11Q34124151-3519BCAC-AE7D-4B0E-99DE-CE1D8611C707Q34284209-CC866DE6-2467-41E9-BCF5-341DF52D9E6EQ34441198-D1E4965E-2DCD-4EA2-B62D-912F283D9B20Q34454568-65B768C5-4FB0-467C-ACC8-2B6D2667864AQ34460922-6E6609DA-FB86-47C6-ACB2-59C3E389E815Q34662297-47EC6AEC-ECFD-4987-A99F-E9B34F54071EQ34997094-E4EEDCA5-847F-4088-B1F4-F79C1EADC62CQ35184642-23122885-E760-4697-AE03-8AA524E04C83Q35376284-199CE7D6-0DB7-4511-BEAC-A1A7D3EEB5CAQ35601249-E1AC2469-DFCE-467D-8B9B-5E6FC98A37ECQ35608757-8E50179D-64D1-426E-ACBD-6B942F8C6157Q35674559-E4122840-FFE5-4D47-AA62-7EE15A7ACC85Q35962266-40EAF186-7A1C-4CC7-9F47-1BE04C225970Q36003155-C935FE77-1DAC-40C4-B0AF-9B169754024EQ36042250-716CA404-17C1-47EC-B6AB-764673619688Q36071880-4E12432E-A237-403F-AA54-6443382AC518Q36187022-C1A50FCB-97C6-4BCC-B8E4-F8DE8E4ABC83Q36244921-A88B08C7-EC4C-4AEC-B0F9-E3D39F9A65FAQ36396061-553524CF-B472-4906-96B3-4003478903CAQ36737285-33108FDE-8DE8-486E-B22E-094385CAE283Q36795404-57FC4DC9-8000-402F-BCA4-A81AF9AC2E68
P2860
Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Role of PPARgamma in regulatin ...... f1/Cip1), during adipogenesis.
@en
Role of PPARgamma in regulatin ...... f1/Cip1), during adipogenesis.
@nl
type
label
Role of PPARgamma in regulatin ...... f1/Cip1), during adipogenesis.
@en
Role of PPARgamma in regulatin ...... f1/Cip1), during adipogenesis.
@nl
prefLabel
Role of PPARgamma in regulatin ...... f1/Cip1), during adipogenesis.
@en
Role of PPARgamma in regulatin ...... f1/Cip1), during adipogenesis.
@nl
P2860
P356
P1476
Role of PPARgamma in regulatin ...... f1/Cip1), during adipogenesis.
@en
P2093
Morrison RF
P2860
P304
17088-17097
P356
10.1074/JBC.274.24.17088
P407
P577
1999-06-01T00:00:00Z